Glen Harbor Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Glen Harbor Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$45K	Buy	1,394 +952	+215%	+$39.4K	﹤0.01%	1236
2019 Q2	$22K	Sell	442 -6,222	-93%	-$333K	﹤0.01%	1295
2019 Q1	$449K	Buy	6,664 +1,972	+42%	+$115K	0.01%	714
2018 Q4	$216K	Buy	4,692 +4,454	+1,871%	+$275K	0.01%	922
2018 Q3	$18K	Sell	238 -442	-65%	-$35.6K	﹤0.01%	1266
2018 Q2	$57K	Buy	680 +612	+900%	+$53.4K	﹤0.01%	1207
2018 Q1	$6K	Buy	+68	New	+$5.26K	﹤0.01%	1282

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Glen Harbor Capital Management's AGIO Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 215% in Q3 2019, buying an estimated $39.4K and bringing the position to 1,394 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #1236.

Glen Harbor Capital Management first reported a position in AGIO in Q1 2018 and has held it in 7 quarters since. The position peaked at $449K in Q1 2019. 189 funds tracked by Wall St. Rank hold AGIO as of Q3 2019.

Glen Harbor Capital Management held 1,394 shares of Agios Pharmaceuticals worth $45K as of Q3 2019.
Glen Harbor Capital Management bought 952 Agios Pharmaceuticals shares in Q3 2019, an estimated $39.4K.
Agios Pharmaceuticals made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1236 holding.
Glen Harbor Capital Management first reported a position in Agios Pharmaceuticals in Q1 2018 and has held it in 7 quarters since.
Glen Harbor Capital Management's Agios Pharmaceuticals position peaked at $449K in Q1 2019.
189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.